Literature DB >> 30996070

Myopathy in a 61-year-old Hispanic man.

Gary Parizher1, Timothy J Brown1, Mary Hon1, Elena K Joerns1, Yu Zuo1.   

Abstract

A 61-year-old Hispanic man presented to a county hospital for subacute progressive weakness, heliotrope rash and dysphagia. There was initial suspicion for dermatomyositis (DM) given the history; however, the physical exam was not consistent. An MRI followed by a muscle biopsy revealed necrotising autoimmune myositis and anti-3-hydroxy-3-methylglutary-coenzyme A-reductase antibody titers returned positive; the patient was diagnosed with necrotising autoimmune myositis. He was treated with corticosteroids and intravenous immunoglobulin, which resulted in improvement in his weakness and functional status. This case represents a unique instance in which a cardinal feature of DM, the heliotrope rash, prompted an erroneous initial diagnosis. It highlights the necessity of developing abroad differential diagnosis and subsequent thorough investigation into patients presenting with suspected idiopathic immune-mediated myopathies. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drugs: musculoskeletal and joint diseases; musculoskeletal syndromes; rheumatology

Mesh:

Substances:

Year:  2019        PMID: 30996070      PMCID: PMC6506082          DOI: 10.1136/bcr-2018-228892

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

1.  Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.

Authors:  Ritu Valiyil; Livia Casciola-Rosen; Grace Hong; Andrew Mammen; Lisa Christopher-Stine
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-09       Impact factor: 4.794

2.  Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.

Authors:  Andrew L Mammen; Eleni Tiniakou
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

3.  More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors:  Eleni Tiniakou; Iago Pinal-Fernandez; Thomas E Lloyd; Jemima Albayda; Julie Paik; Jessie L Werner; Cassie A Parks; Livia Casciola-Rosen; Lisa Christopher-Stine; Andrew L Mammen
Journal:  Rheumatology (Oxford)       Date:  2017-05-01       Impact factor: 7.580

Review 4.  Treatment in myositis.

Authors:  Chester V Oddis; Rohit Aggarwal
Journal:  Nat Rev Rheumatol       Date:  2018-03-29       Impact factor: 20.543

5.  Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors:  Jessie L Werner; Lisa Christopher-Stine; Sharon R Ghazarian; Katherine S Pak; Jordan E Kus; Natalie R Daya; Thomas E Lloyd; Andrew L Mammen
Journal:  Arthritis Rheum       Date:  2012-12

6.  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature.

Authors:  S Barsotti; E Cioffi; A Tripoli; A Tavoni; A D'Ascanio; M Mosca; R Neri
Journal:  Reumatismo       Date:  2018-07-06

Review 7.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

8.  Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition.

Authors:  Tom J J Schirris; G Herma Renkema; Tina Ritschel; Nicol C Voermans; Albert Bilos; Baziel G M van Engelen; Ulrich Brandt; Werner J H Koopman; Julien D Beyrath; Richard J Rodenburg; Peter H G M Willems; Jan A M Smeitink; Frans G M Russel
Journal:  Cell Metab       Date:  2015-09-01       Impact factor: 27.287

Review 9.  Classification, diagnosis, and management of idiopathic inflammatory myopathies.

Authors:  Ilias N Lazarou; Pierre-André Guerne
Journal:  J Rheumatol       Date:  2013-03-15       Impact factor: 4.666

10.  Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.

Authors:  Cecilie Dobloug; Torhild Garen; Helle Bitter; Johan Stjärne; Guri Stenseth; Lars Grøvle; Marthe Sem; Jan Tore Gran; Øyvind Molberg
Journal:  Ann Rheum Dis       Date:  2014-04-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.